The main goal of precision medicine in patients with breast cancer is to tailor the treatment according to the particular genetic makeup and the genetic changes in the cancer cells. Breast cancer occurring during pregnancy (BCP) is a complex and difficult clinical problem. Although it is not very common, both maternal and fetal outcome must be always considered when planning treatment. Pregnancy represents a significant barrier to the implementation of personalized treatment for breast cancer. Tailoring therapy mainly takes into account the stage of pregnancy, the subtype of cancer, the stage of cancer, and the patient's preference. Results of the treatment of breast cancer in pregnancy are as yet not very satisfactory because of often delayed diagnosis, and it usually has an unfavorable outcome. Treatment of patients with pregnancy-associated breast cancer should be centralized. Centralization may result in increased experience in diagnosis and treatment and accumulated data may help us to optimize the treatment approaches, modify general treatment recommendations, and improve the survival and quality of life of the patients.

Department of Gynecology and Obstetrics 1st Faculty of Medicine Charles University and General University Hospital 128 08 Prague Czech Republic

Department of Oncology 1st Faculty of Medicine Charles University and General University Hospital 128 08 Prague Czech Republic

Zobrazit více v PubMed

Peccatori F.A., Lambertini M., Scarfone G., Del Pup L., Codacci-Pisanelli G. Biology, staging, and treatment of breast cancer during pregnancy: Reassessing the evidences. Cancer Biol. Med. 2018;15:6–13. doi: 10.20892/j.issn.2095-3941.2017.0146. PubMed DOI PMC

Borges V.F., Schedin P.J. Pregnancy-associated breast cancer: An entity needing refinement of the definition. Cancer. 2012;118:3226–3228. doi: 10.1002/cncr.26643. PubMed DOI PMC

Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. PubMed DOI

Low S.K., Zembutsu H., Nakamura Y. Breast cancer: The translation of big genomic data to cancer precision medicine. Cancer Sci. 2018;109:497–506. doi: 10.1111/cas.13463. PubMed DOI PMC

Parazzini F., Franchi M., Tavani A., Negri E., Peccatori F.A. Frequency of pregnancy related cancer: A population based linkage study in Lombardy, Italy. Int. J. Gynecol. Cancer. 2017;27:613–619. doi: 10.1097/IGC.0000000000000904. PubMed DOI

Litton J.K. Gestational Breast Cancer: Epidemiology and Diagnosis. [(accessed on 19 November 2020)];2020 Available online: https://www.uptodate.com/contents/gestational-breast-cancer-epidemiology-and-diagnosis.

Wohlfahrt J., Andersen P.K., Mouridsen H.T., Melbye M. Risk of late-stage breast cancer after childbirth. Am. J. Epidemiol. 2001;153:1079–1084. doi: 10.1093/aje/153.11.1079. PubMed DOI

Ruiz R., Herrero C., Strasser-Weippl K., Touya D., St Louis J., Bukowski A., Goss P.E. Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review. Breast. 2017;35:136–141. doi: 10.1016/j.breast.2017.07.008. PubMed DOI

Schedin P. Pregnancy-associated breast cancer and metastasis. Nat. Rev. Cancer. 2006;6:281–291. doi: 10.1038/nrc1839. PubMed DOI

Slocum E., Craig A., Villanueva A., Germain D. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2. Breast Cancer Res. 2019;21:56. doi: 10.1186/s13058-019-1142-z. PubMed DOI PMC

Callihan E.G., Gao D., Jindal S., Lyons T.R., Manthey E., Edgerton S., Urquhart A., Schedin P., Borges V.F. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res. Treat. 2013;138:549–559. doi: 10.1007/s10549-013-2437-x. PubMed DOI PMC

Nguyen B., Venet D., Azim H.A., Jr., Brown D., Desmedt C., Lambertini M., Majjaj S., Pruneri G., Peccatori F., Piccart M., et al. Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations. NPJ Breast Cancer. 2018;4:23. doi: 10.1038/s41523-018-0077-3. PubMed DOI PMC

Middleton L.P., Amin M., Gwyn K., Theriault R., Sahin A. Breast carcinoma in pregnant women: Assessment of clinicopathologic and immunohistochemical features. Cancer. 2003;98:1055–1060. doi: 10.1002/cncr.11614. PubMed DOI

Reed W., Hannisdal E., Skovlund E., Thoresen S., Lilleng P., Nesland J.M. Pregnancy and breast cancer: A population-based study. Virchows Arch. 2003;443:44–50. doi: 10.1007/s00428-003-0817-z. PubMed DOI

Collins L.C., Gelber S., Marotti J.D., White S., Ruddy K., Brachtel E.F., Schapira L., Come S.E., Borges V.F., Schedin P., et al. Molecular phenotype of breast cancer according to time since last pregnancy in a large cohort of young women. Oncologist. 2015;20:713–718. doi: 10.1634/theoncologist.2014-0412. PubMed DOI PMC

Korakiti A.-M., Moutafi M., Zografos E., Dimopoulos M.A., Zagouri F. The genomic profile of pregnancy-associated breast cancer: A systematic review. Front. Oncol. 2020;10:1773. doi: 10.3389/fonc.2020.01773. PubMed DOI PMC

Ghasemi M., Nabipour I., Omrani A., Alipour Z., Assadi M. Precision medicine and molecular imaging: New targeted approaches toward cancer therapeutic and diagnosis. Am. J. Nuclear Med. Mol. Imaging. 2016;6:310–327. PubMed PMC

Mandrekar S.J., Sargent D.J. Clinical trial designs for predictive biomarker validation: Theoretical considerations and practical challenges. J. Clin. Oncol. 2009;27:4027–4034. doi: 10.1200/JCO.2009.22.3701. PubMed DOI PMC

Polley M.Y.C., Freidlin B., Korn E.L., Conley B.A., Abrams J.S., McShane L.M. Statistical and practical considerations for clinical evaluation of predictive biomarkers. J. Natl. Cancer Inst. 2013;105:1677–1683. doi: 10.1093/jnci/djt282. PubMed DOI PMC

Sotiriou C., Neo S.Y., McShane L.M., Korn E.L., Long P.M., Jazaeri A., Martiat P., Fox S.B., Harris A.L., Liu E.T. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc. Natl. Acad. Sci. USA. 2003;100:10393–10398. doi: 10.1073/pnas.1732912100. PubMed DOI PMC

Wang Y., Yin Q., Yu Q., Zhang J., Liu Z., Wang S., Lv S., Niu Y. A retrospective study of breast cancer subtypes: The risk of relapse and the relations with treatments. Breast Cancer Res. Treat. 2011;130:489–498. doi: 10.1007/s10549-011-1709-6. PubMed DOI

Meehan J., Gray M., Martínez-Pérez C., Kay C., Pang L.Y., Fraser J.A., Poole A.V., Kunkler I.H., Langdon S.P., Argyle D., et al. Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer. Front Oncol. 2020;10:628. doi: 10.3389/fonc.2020.00628. PubMed DOI PMC

Pantel K., Speicher M.R. The biology of circulating tumor cells. Oncogene. 2016;35:1216–1224. doi: 10.1038/onc.2015.192. PubMed DOI

Burrell R.A., McGranahan N., Bartek J., Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501:338–345. doi: 10.1038/nature12625. PubMed DOI

Pasculli B., Barbano R., Parrella P. Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine. Semin Cancer Biol. 2018;51:22–35. doi: 10.1016/j.semcancer.2018.01.007. PubMed DOI

Nicolini A., Ferrari P., Duffy M.J. Prognostic and predictive biomarkers in breast cancer: Past, present and future. Semin Cancer Biol. 2018;52:56–73. doi: 10.1016/j.semcancer.2017.08.010. PubMed DOI

Lethaby A.E., O’Neill M.A., Mason B.H., Holdaway I.M., Harvey V.J. Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int. J. Cancer. 1996;67:751–755. doi: 10.1002/(SICI)1097-0215(19960917)67:6<751::AID-IJC1>3.0.CO;2-Q. PubMed DOI

Byrd B.F., Jr., Bayer D.S., Robertson J.C., Stephenson S.E., Jr. Treatment of breast tumors associated with pregnancy and lactation. Ann. Surg. 1962;155:940–947. doi: 10.1097/00000658-196215560-00014. PubMed DOI PMC

Yang W.T., Dryden M.J., Gwyn K., Whitman G.J., Theriault R. Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy. Radiology. 2006;239:52–60. doi: 10.1148/radiol.2391050083. PubMed DOI

Collins J.C., Liao S., Wile A.G. Surgical management of breast masses in pregnant women. J. Reprod. Med. 1995;40:785–788. doi: 10.1097/00006254-199606000-00004. PubMed DOI

Annane K., Bellocq J.P., Brettes J.P., Mathelin C. Infiltrative breast cancer during pregnancy and conservative surgery. Fetal. Diagn. Ther. 2005;20:442–444. doi: 10.1159/000087114. PubMed DOI

Case A.S. Pregnancy-associated Breast Cancer. Clin. Obstet. Gynecol. 2016;59:779–788. doi: 10.1097/GRF.0000000000000235. PubMed DOI

Nicklas A.H., Baker M.E. Imaging strategies in the pregnant cancer patient. Semin. Oncol. 2000;27:623–632. PubMed

Chen M.M., Coakley F.V., Kaimal A., Laros R.K., Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet. Gynecol. 2008;112:333–340. doi: 10.1097/AOG.0b013e318180a505. PubMed DOI

Chen J., Prasath V., Axilbund J., Habibi M. Concerns of Hereditary Breast Cancer in Pregnancy and Lactation. Adv. Exp. Med. Biol. 2020;1252:129–132. doi: 10.1007/978-3-030-41596-9_17. PubMed DOI

Cullinane C.A., Lubinski J., Neuhausen S., Ghadirian P., Lynch H.T., Isaacs C., Weber B., Moller P., Offit K., Kim-Sing C., et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int. J. Cancer. 2005;117:988–991. doi: 10.1002/ijc.21273. PubMed DOI

Johansson O., Loman N., Borg A., Olsson H. Pregnancy-associated breast cancer. Lancet. 1998;352:1359–1360. doi: 10.1016/S0140-6736(05)60750-7. PubMed DOI

Azim H.A., Jr., Del Mastro L., Scarfone G., Peccatori F.A. Treatment of breast cancer during pregnancy: Regimen selection, pregnancy monitoring and more. Breast. 2011;20:1–6. doi: 10.1016/j.breast.2010.10.008. PubMed DOI

Keyser E.A., Staat B.C., Fausett M.B., Shields A.D. Pregnancy-associated breast cancer. Rev. Obstet. Gynecol. 2012;5:94–99. PubMed PMC

Hartman E.K., Eslick G.D. The prognosis of women diagnosed with breast cancer before, during and after pregnancy: A meta-analysis. Breast Cancer Res. Treat. 2016;160:347–360. doi: 10.1007/s10549-016-3989-3. PubMed DOI

Amant F., von Mickwitz G., Han S.N., Bontenbal M., Ring A.E., Giermek J., Wildiers H., Fehm T., Linn S.C., Schlehe B., et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: Results from an international collaborative study. J. Clin. Oncol. 2013;31:2532–2539. doi: 10.1200/JCO.2012.45.6335. PubMed DOI

Peccatori F.A., Azim H.A., Jr., Orecchia R., Hoekstra H.J., Pavlidis N., Kesic V., Pentheroudakis G., ESMO Guidelines Working Group Cancer, pregnancy and fertility. ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013;24:vi160–vi170. doi: 10.1093/annonc/mdt199. PubMed DOI

Litton J.K., Warneke C.L., Hahn K.M., Palla S.L., Kuerer H.M., Perkins G.H., Mittendorf E.A., Barnett C., Gonzalez-Angulo A.M., Horgobágyi G.N., et al. Case control study of women treated with chemotherapy for breast cancer during pregnancy as compared with nonpregnant patients with breast cancer. Oncologist. 2013;18:369–376. doi: 10.1634/theoncologist.2012-0340. PubMed DOI PMC

Azim H.A., Santoro L., Jr., Russell-Edu W., Pentheroudakis G., Pavlidis N., Peccatori F.A. Prognosis of pregnancy-associated breast cancer: A meta-analysis of 30 studies. Cancer Treat. Rev. 2012;38:834–842. doi: 10.1016/j.ctrv.2012.06.004. PubMed DOI

Loibl S., Schmidt A., Gentilini O., Kaufman B., Kuhl C., Denkert C., von Mickwitz G., Parokonnaya A., Stensheim H., Thomssen C., et al. Breast cancer diagnosed during pregnancy: Adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015;1:1145–1153. doi: 10.1001/jamaoncol.2015.2413. PubMed DOI

Folsom S.M., Woodruff T.K. Good news on the active management of pregnant cancer patients. F1000 Res. 2020;9 doi: 10.12688/f1000research.22472.1. PubMed DOI PMC

Paulsson A.K., Braunstein S., Phillips J., Theodosopoulos P.V., McDermott M., Sneed P.K., Ma L. Patient-specific fetal dose determinatioin for multi-target gamma knife radiosurgery: Computational model and case report. Cureus. 2017;9:e1527. PubMed PMC

Ringley J.T., Moore D.C., Patel J., Rose M.S. Poly (ADP-ribose) polymerase inhibitors in the management of ovarian cancer: A drug class review. Pharm. Ther. 2018;32:549–556. PubMed PMC

Litton J.K. Gestational Breast Cancer: Treatment. [(accessed on 19 November 2020)];2020 Available online: https://www.uptodate.com/contents/gestational-breast-cancer-treatment.

Khera S.Y., Kiluk J.V., Hasson D.M., Meade T.M., Meyers M.P., Dupont E.L., Berman C.G., Cox C.E. Pregnancy-associated breast cancer patients can safely undergo lymphatic mapping. Breast J. 2008;14:250–254. doi: 10.1111/j.1524-4741.2008.00570.x. PubMed DOI

Boere I., Lok C., Vandenbroucke T., Amant F. Cancer in pregnancy: Safety and efficacy of systemic therapies. Curr. Opin. Oncol. 2017;29:328–334. doi: 10.1097/CCO.0000000000000386. PubMed DOI

Wiebe V.J., Sipila P.E. Pharmacology of antineoplastic agents in pregnancy. Crit. Rev. Oncol. Hematol. 1994;16:75–112. doi: 10.1016/1040-8428(94)90043-4. PubMed DOI

Gziri M.M., Hui W., Amant F., Van Calsteren K., Ottevanger N., Kapusta L., Mertens L. Myocardial function in children after fetal chemotherapy exposure. A tissue Doppler and myocardial deformation imaging study. Eur. J. Pediatr. 2013;172:163–170. doi: 10.1007/s00431-012-1849-7. PubMed DOI

Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5:283–291. doi: 10.1016/S1470-2045(04)01466-4. PubMed DOI

Murthy R.K., Theriault R.L., Barnett C.M., Hodge S., Ramirez M.M., Milbourne A., Rimes S.A., Hortobagyi G.N., Valero V., Litton J.K. Outcomes of children exposed in utero to chemotherapy for breast cancer. Breast Cancer Res. 2014;16:500. doi: 10.1186/s13058-014-0500-0. PubMed DOI PMC

Amant F., Deckers S., Van Calsteren K., Loibl S., Halaska M., Brepoels L., Beijnen J., Cardoso F., Gentilini O., Lagae L., et al. Breast cancer in pregnancy: Recommendations of an international consensus meeting. Eur. J. Cancer. 2010;46:3158–3168. doi: 10.1016/j.ejca.2010.09.010. PubMed DOI

Hahn K.M., Johnson P.H., Gordon N., Kuerer H., Middleton L., Ramirez M., Yang W., Perkins G., Hortobagyi N., Theriault R.L. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219–1226. doi: 10.1002/cncr.22081. PubMed DOI

Mir O., Berveiller P., Ropert S., Goffinet F., Goldwasser F. Use of platinum derivatives during pregnancy. Cancer. 2008;113:3069–3074. doi: 10.1002/cncr.23935. PubMed DOI

Cardonick E., Gilmandyar D., Somer R.A. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet. Gynecol. 2012;120:1267–1272. doi: 10.1097/AOG.0b013e31826c32d9. PubMed DOI

Ring A.E., Smith I.E., Jones A., Shannon C., Galani E., Ellis P.A. Chemotherapy for breast cancer during pregnancy: An 18-year experience from five London teaching hospitals. J. Clin. Oncol. 2005;23:4192–4197. doi: 10.1200/JCO.2005.03.038. PubMed DOI

Zagouri F., Sergentanis T.N., Chrysikos D., Papadimitriou C.A., Dimopoulos M.A., Bartsch R. Trastuzumab administration during pregnancy: A systematic review and meta-analysis. Breast Cancer Res. Treat. 2013;137:349–357. doi: 10.1007/s10549-012-2368-y. PubMed DOI

Lambertini M., Martel S., Campbell C., Guillaume S., Hilbers F.S., Schuehly U., Korde L., Azim H.A., Di Cosimo S., Jr., Tenglin R.C., et al. Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials. Cancer. 2019;125:307–316. doi: 10.1002/cncr.31784. PubMed DOI

Kelly H., Graham M., Humes E., Dorflinger L.J., Boggess K.A., O’Neil B.H., Harris J., Spector N.L., Dees E.C. Delivery of a healthy baby after first-trimester maternal exposure to lapatinib. Clin. Breast Cancer. 2006;7:339–341. doi: 10.3816/CBC.2006.n.048. PubMed DOI

Lambertini M., Di Maio M., Pagani O., Curigliano G., Poggio F., Del Mastro L., Paluch-Shimon S., Loibl S., Partridge A.H., Demeestere I., et al. The BCY3/BCC 2017 survey on physicians’ knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. Breast. 2018;4:41–49. doi: 10.1016/j.breast.2018.08.099. PubMed DOI

Buonomo B., Brunello A., Noli S., Miglietta L., Del Mastro L., Lambertini M., Peccatori F.A. Tamoxifen exposure during pregnancy: A systematic review and three more cases. Breast Care. 2020;15:148–156. doi: 10.1159/000501473. PubMed DOI PMC

Bilgin K., Yaramiş A., Haspolat K., Taş M.A., Gunbey S., Derman O. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics. 2001;107:36–41. doi: 10.1542/peds.107.1.36. PubMed DOI

Rojas K.E., Bilbro N., Manasseh D.M., Borgen P.I.J. A review of pregnancy-associated breast cancer: Diagnosis, local and systemic treatment and prognosis. Womens Health. 2019;28:778–784. doi: 10.1089/jwh.2018.7264. PubMed DOI

Nettleton J., Long J., Kuban D., Wu R., Shaeffer J., El-Mahdi A. Breast cancer during pregnancy: Quantifying the risk of treatment delay. Obstet. Gynecol. 1996;87:414–418. doi: 10.1016/0029-7844(95)00470-X. PubMed DOI

Amant F., Vandenbroucke T., Verheecke M., Fungalli M., Halaska M.J., Boere I., Han S., Gziri M.M., Peccatori F., Rob L., et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. N. Engl. J. Med. 2015;373:1824–1834. doi: 10.1056/NEJMoa1508913. PubMed DOI

de Haan J., Verheecke M., Van Calsteren K., Van Calster B., Shmakov R.G., Gziri M., Halaska M.J., Fruscio R., Lok C.A.R., Boere I.A., et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: A 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19:337–346. doi: 10.1016/S1470-2045(18)30059-7. PubMed DOI

Rodriguez A.O., Chew H., Cress R., Xing G., McElvy S., Danielsen B., Smith L. Evidence of poorer survival in pregnancy associated breast cancer. Obstet. Gynecol. 2008;112:71–78. doi: 10.1097/AOG.0b013e31817c4ebc. PubMed DOI

Tang T., Liu Y., Yang C., Ma L. Diagnosis and treatment of advanced HER2-positive breast cancer in young pregnant female: A case report. Medicine. 2020;99:e22929. doi: 10.1097/MD.0000000000022929. PubMed DOI PMC

Kern R., Correa S.C., Scandolara T.B., Carla da Silva J., Pires B.R., Panis C. Current advances in the diagnosis and personalized treatment of breast cancer: Lessons from tumor biology. Per. Med. 2020;17:399–420. doi: 10.2217/pme-2020-0070. PubMed DOI